2019 Financial Considerations
IPM’s cash, cash equivalents and short-term investments as of Dec. 31, 2019, totaled USD 23.6 million. In 2019, IPM advanced five major programs:
In 2019, IPM received support from donors including the Ministry of Foreign Affairs of Denmark; the Flanders Department of Foreign Affairs; the German Federal Ministry of Education and Research; Irish Aid; the Ministry of Foreign Affairs of the Netherlands; the UK Foreign, Commonwealth and Development Office (then the Department for International Development); the US President’s Emergency Plan for AIDS Relief through the US Agency for International Development; and the Bill & Melinda Gates Foundation. IPM received approximately USD 29.2 million (cash receipts) in 2019.
IPM’s 2019 financial audits continue a history of full compliance with all financial reporting requirements from all US and international government and private donors. In 2019, IPM again received an unmodified, or clean, audit opinion across its South Africa, US and Belgium offices.
IPM’s Board of Directors, leadership team and staff remain committed to efficiently and effectively delivering on our mission to develop HIV prevention and other sexual and reproductive health technologies for women, and to make them available and accessible where they are urgently needed. Woman-centered technologies like the long-acting dapivirine ring could help fill an important gap in the existing HIV prevention portfolio, especially in sub-Saharan Africa. With the EMA’s positive opinion for the ring expected to facilitate country approvals in Africa, sustaining financial support for IPM’s work is essential to empowering women with more options they can use to protect their sexual and reproductive health on their own terms. We continue to advocate for increased funds from existing donors and to pursue new funding sources and partnerships.